The role of the FTO gene (Fat Mass and Obesity-Associated) in weight loss is complex and often misunderstood. FTO variants, especially the risk allele in intron 1 (e.g., rs9939609), are among the strongest genetic markers associated with obesity. Carriers of the risk allele tend to have a higher BMI and increased caloric intake, likely due to altered appetite regulation (e.g., reduced satiety). However, having the risk allele does not make weight loss impossible. Studies show that lifestyle interventions (diet, exercise) are effective across all genotypes – the effect of FTO on weight loss is generally small and overshadowed by environmental factors. There is no specific diet proven to work better for FTO carriers; evidence for genotype-specific dietary recommendations is weak. The gene variant can serve as an indicator of increased risk, but not as a determinant of weight loss success. A DNA test provides only a probabilistic insight, not a diagnosis. Anyone aiming to lose weight should focus on evidence-based strategies (caloric balance, fiber, physical activity), regardless of FTO status.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-d59171852e18d08e1abe8665